BSECompany Update25 Aug 2026 · 25 Aug 2026, 03:01 pm
Transcript of Conference Call with Investors and Analysts held on August 18, 2026
Mitsu Chem Plast Ltd · 540078
✦ AI Summary▲ PositiveResults
Mitsu Chem Plast Ltd reported strong Q1 FY27 earnings, with 11.62% yoy growth in total income, 209.50% yoy increase in EBITDA, and 566.23% yoy growth in net profit. The company also announced a proposed expansion of its manufacturing capacity by 3,550 metric tons per annum.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mitsu Chem Plast Ltd - 540078 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Attachments (1)
📄pdf
Download →
146c8746-fd2e-4527-8b88-5de3b019c2c3.pdf
View document text
Date: August 25, 2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street
Mumbai- 400001
Scrip Code : 540078
Sub: Transcript of Conference Call with Investors and Analysts held on August 18, 2026
Dear Sir/Madam,
With reference to our previous communication dated August 13, 2026 intimating you about the
Conference Call with Investors and Analysts held on August 18, 2026, please find attached transcript
of the aforesaid Conference Call.
Kindly take the same on record.
Thanking you.
Yours truly,
FOR MITSU CHEM PLAST LIMITED
Gargi Sawant
Company Secretary & Compliance Officer
Encl: as above
“Mitsu Chem Plast Limited
Q1 FY27 Earnings Conference Call”
August 18, 2026
MANAGEMENT: MR. MANISH DEDHIA – MANAGING DIRECTOR AND
CHIEF FINANCIAL OFFICER – MITSU CHEM PLAST
LIMITED
MS. KASHMIRA DEDHIA – VICE PRESIDENT – FINANCE
AND ACCOUNTS – MITSU CHEM PLAST LIMITED
MODERATOR: MR. KARAN THAKUR – KIRIN ADVISORS PRIVATE
LIMITED
Page 1 of 16
Mitsu Chem Plast Limited
August 18, 2026
Moderator: Ladies and gentlemen, good day, and welcome to Mitsu Chem Plast Limited Q1 FY27 Earnings
Conference Call. As a reminder, all participant lines will be in the listen-only mode, and there
will be an opportunity for you to ask questions after the presentation concludes. Should you need
assistance during this conference call, please signal an operator by pressing star then zero on
your touchphone phone. Please note that this conference is being recorded.
I now hand the conference over to Mr. Karan Thakur from Kirin Advisors. Thank you, and over
to you, sir.
Karan Thakur: Thank you. On behalf of Kirin Advisors, I welcome you all to the conference call of Mitsu Chem
Plast Limited. From the management team, we have Mr. Manish Dedhia, Managing Director
and Chief Financial Officer; and Ms. Kashmira Dedhia, Vice President, Finance and Accounts.
With that now, I hand over the call to Mr. Manish Dedhia for opening remarks. Over to you, sir.
Manish Dedhia: Thank you. Good afternoon, everyone. It is a pleasure to welcome all investors, analysts and
participants to the Mitsu Chem Plast Limited Q1 FY27 Earnings Conference Call. We sincerely
appreciate your continued support and interest in our company. Q1 FY27 reflected continued
progress for Mitsu Chem Plast Limited with focus on strengthening our manufacturing
capabilities, improving operational efficiencies and supporting growth across our diversified
product portfolio.
During the quarter, the company continued to build on its capabilities across industrial
packaging, health care, infrastructure and other value-added applications. We are also pleased
to announce a proposed addition of 3,550 metric tons per annum to our existing manufacturing
capacity of 32,450 metric ton per annum overall.
This expansion is aimed at strengthening our ability to cater to growing demand across key
products segments and supporting the company's long-term growth plan. Our existing capacity
utilization stood at 64% in FY26, providing a strong base for further product and capacity
expansion.
Our diversified product portfolio continues to remain a key strength. We operate across blow
molding, injection molding and custom molding applications, serving industries, including
pharmaceuticals, chemicals, agrochemical, FMCG, food, health care and other industrial
segments.
The company currently operates four manufacturing facilities with 53 blow molding machines
and 22 injection molding machines and installed capacity of more than 32,450 metric tons per
annum.
Healthcare furniture remains an important growth opportunity for the company through our
Furnastra brand. Furnastra is focused on innovative and durable hospital furniture components
with an emphasis on quality, ergonomic design and customer-centric solutions. We continue to
see opportunity to strengthen this vertical and expand its market presence.
Page 2 of 16
Mitsu Chem Plast Limited
August 18, 2026
Our packaging portfolio also remains an important area of focus with continued emphasis on
products such as paint containers, jerry cans and specialized caps and closures. This initiative
are aligned with our broader transformation strategy focused on operational excellence, data-
driven marketing, scientific innovation and empowered teams.
This company also continued to maintain a strong export presence across 17 countries, supported
by a diversified customer base across pharmaceutical, health care, chemical, FMCG and other
industries. Our in-house R&D design and value engineering capabilities further support our
ability to develop customized and value-added solutions for customers.
The company delivered a strong financial performance during Q1 FY 2027. Total income grew
11.62% year-on-year, while EBITDA increased by 209.50%, supported by improved operating
efficiencies and a stronger product mix. Net profit increased by 566.23% year-on-year, reflecting
a significant improvement in overall profitability.
Going forward, our focus remains on expanding manufacturing capacity, strengthening our
product portfolio, improving operational efficiencies and leveraging opportunities across
industrial and packaging segments.
We remain committed to building sustainable growth and creating long-term value for all our
stakeholders. Before concluding, I would like to thank our employees, customers, business
partners and shareholders for their continued trust and support.
With this, I conclude my remarks and I now request Ms. Kashmira Dedhia to take you through
the financial performance for the quarter ended June 30, 2026.
Kashmira Dedhia: Thank you. Good afternoon, everyone. I will now take you through the financial highlights for
quarter 1 FY27. For the first quarter of financial year '27, Mitsu Chem Plast Limited reported
strong improvement in profitability, supported by better operating efficiency and improved
product mix.
Total income for the quarter stood at INR 9,532.78 lakhs, registering a growth of 11.62% year-
on-year compared to INR 8,540.39 lakhs in quarter 1 FY2026. EBITDA increased significantly
to INR 1,549.48 lakhs, registering a growth of 209.50% year-on-year. EBITDA margin
improved to 16.29% compared to 5.87% in quarter 1 FY26 representing an expansion of 1041
basis points.
Net profit for quarter 1 FY27 stood at INR 873.83 lakhs, registering a growth of 566.23% year-
on-year compared to INR 131.16 lakhs in quarter 1 FY26. Net profit margin improved to 9.18%
compared to 1.54% in the corresponding quarter last year. Earnings per share for the quarter
stood at INR 6.44 compared to INR 0.97 in quarter 1 FY26.
On a sequential basis, the company also continued to maintain strong profitability. EBITDA
stood at INR 1,549.48 lakhs in quarter 1 FY27 compared to INR 1,422.74 lakhs in quarter 4
FY26, while net profit increased from INR 771.73 lakhs in quarter 4 FY26 to INR 873.83 lakhs
in quarter 1 FY27.
Page 3 of 16
Mitsu Chem Plast Limited
August 18, 2026
The strong improvement in EBITDA and net profit reflects the benefit of improved operating
efficiency and a stronger product mix during the quarter. Looking ahead, our priority remains
focused on capacity expansion, strengthening our diversified product portfolio and improving
operational efficiency.
The proposed addition of 3,550 metric ton per annum to our existing capacity will provide
additional manufacturing capabilities to support growth across key product verticals. We will
continue to focus on higher value-added opportunities across packaging, health care furniture
and other industrial applications.
Our transformation agenda remains cantered around Furnastra, enhanced packaging products,
operational excellence, data-driven marketing, scientific innovation and empowered teams. The
company continues to work towards its long-term objective of achieving INR 1,000 crores in
annual revenue by FY28.
With that, I conclude my financial update. I will now request the moderator to open the floor for
question-and-answers. Thank you.
Moderator: Thank you very much. We will no
[Showing first 8,000 characters — download PDF for full document]